NEOZOTAC is a national , multicenter , randomized study comparing the efficacy of TAC ( docetaxel , adriamycin and cyclophosphamide i.v. ) followed by granulocyte colony-stimulating factor on day @ with or without ZA @ mg i.v. q @ weeks inpatients withstage II/III , HER@-negative BC .